Oregon Drug Pricing Transparency Law Remains In Effect
A U.S. Circuit Court of Appeals panel ruled 2-1 that the 2018 law does not violate drugmakers’ constitutional rights
Read More
EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company
EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company. The post EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company appeared first on MedCity News.
European Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option
Zemcelpro, a cord blood-sourced cell therapy developed by startup ExCellThera, received conditional marketing authorization in Europe as a treatment for blood cancer patients who can’t find a matched donor. It’s the first cell therapy approved in Europe for this group of patients. The post European Commission Approval Gives Blood Cancer Patients a New Cell Therapy…
CDC Director Ousted After Less Than a Month on the Job
Susan Monarez has left her role as CDC director after less than a month — the shortest tenure in the agency’s history — following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters….
Arcadia CMO on Data Challenges Facing Health Plan Leaders
Data platform company’s Luke Hansen, M.D., M.H.S., talks about why advanced analytics and AI are an untapped opportunity for payers
Premier Leaders Praise Growth Potential of IllumiCare Acquisition
The company paid about $40 million for the clinical decision support software in June and executives say it can deliver clients a 10-to-1 return on their investment.
Do people like to daydream?
Not really. At least according a study by Wilson et al. 2025 in Science. In 11 studies, we found that participants typically did not enjoy spending 6 to 15 minutes in a room by themselves with nothing to do but think, that they enjoyed doing mundane external activities much more, and that many preferred to…
Bringing Clinical Data Management to the Cloud
Moving clinical data management to cloud platforms can carry myriad benefits for healthcare organizations. The post Bringing Clinical Data Management to the Cloud appeared first on MedCity News.
CMS doesn’t consider QALYs – What’s a health economist to do?
That is the title of my article out today in The Evidence Base. Here is an excerpt: The Centers for Medicare and Medicaid Services (CMS) are now setting drug prices under the Medicare Drug Price Negotiation program. Unlike other health technology assessment (HTA) bodies worldwide, however, CMS will not consider quality-adjusted life years (QALYs) when setting drug…
How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems?
The path to a sustainable HaH program looks different for regional systems. A smaller, more focused program, designed around their unique needs, can deliver strong clinical and operational value. The post How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems? appeared first on MedCity News.